目前已从分子水平筛选和鉴定出多种人类肿瘤抗原,这不仅有助于阐明肿瘤免疫的分子机制,而且促进了新的肿瘤免疫治疗方法的发展。应用SEREX技术筛选肺癌相关抗原,将为肺癌的早期诊断、免疫治疗和预后监测奠定基础,并为鉴定肺癌相关分子标志物提供候选抗原。 At present, many kinds of human tumor antigens have been screened and identified from the molecular level, which not only help elucidate the molecular mechanism of tumor immunity, but also promote the development of new tumor immunotherapy methods. The application of SEREX technology in the screening of lung cancer-related antigens will lay a foundation for the early diagnosis, immunotherapy and prognosis monitoring of lung cancer and provide candidate antigens for the identification of lung cancer-related molecular markers.